Literature DB >> 25215553

Response to comments by Seaman et al. on "Analysis of longitudinal trials with protocol deviation: a framework for relevant, accessible assumptions, and inference via multiple imputation," Journal of Biopharmaceutical Statistics 23:1352-1371.

J R Carpenter1, J H Roger, S Cro, M G Kenward.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 25215553     DOI: 10.1080/10543406.2014.960085

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


× No keyword cloud information.
  6 in total

1.  Are there really only 2 kinds of people in the world? Evaluating the distribution of change from baseline in pain clinical trials.

Authors:  Omar B Mbowe; Jennifer S Gewandter; Dennis C Turk; Robert H Dworkin; Michael P McDermott
Journal:  Pain       Date:  2020-01       Impact factor: 7.926

2.  Estimands and missing data in clinical trials of chronic pain treatments: advances in design and analysis.

Authors:  Xueya Cai; Jennifer S Gewandter; Hua He; Dennis C Turk; Robert H Dworkin; Michael P McDermott
Journal:  Pain       Date:  2020-10       Impact factor: 7.926

3.  Information-anchored sensitivity analysis: theory and application.

Authors:  Suzie Cro; James R Carpenter; Michael G Kenward
Journal:  J R Stat Soc Ser A Stat Soc       Date:  2018-11-16       Impact factor: 2.483

4.  Reference-based sensitivity analysis for time-to-event data.

Authors:  Andrew Atkinson; Michael G Kenward; Tim Clayton; James R Carpenter
Journal:  Pharm Stat       Date:  2019-07-15       Impact factor: 1.894

5.  Reference-based sensitivity analysis via multiple imputation for longitudinal trials with protocol deviation.

Authors:  Suzie Cro; Tim P Morris; Michael G Kenward; James R Carpenter
Journal:  Stata J       Date:  2016-04       Impact factor: 2.637

6.  A causal modelling framework for reference-based imputation and tipping point analysis in clinical trials with quantitative outcome.

Authors:  Ian R White; Royes Joseph; Nicky Best
Journal:  J Biopharm Stat       Date:  2019-11-12       Impact factor: 1.051

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.